Alkermes plc. — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2022-02-16

Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-16	Ordinary Shares	M	3375	—	Acquired	12871	Direct
2022-02-16	Ordinary Shares	F	1069	$26.79	Disposed	11802	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-16	Restricted Stock Unit Award	$0	M	3375	Disposed		Ordinary Shares (3375)	Direct

Footnotes

F1: Restricted stock units convert into ordinary shares on a one-for-one basis.

F2: This award is fully vested in accordance with its terms.